317 related articles for article (PubMed ID: 30714209)
1. Evaluation of salivary metabolomics in oral leukoplakia and oral squamous cell carcinoma.
Sridharan G; Ramani P; Patankar S; Vijayaraghavan R
J Oral Pathol Med; 2019 Apr; 48(4):299-306. PubMed ID: 30714209
[TBL] [Abstract][Full Text] [Related]
2. Serum metabolomics in oral leukoplakia and oral squamous cell carcinoma.
Sridharan G; Ramani P; Patankar S
J Cancer Res Ther; 2017; 13(3):556-561. PubMed ID: 28862226
[TBL] [Abstract][Full Text] [Related]
3. Salivary metabolite signatures of oral cancer and leukoplakia.
Wei J; Xie G; Zhou Z; Shi P; Qiu Y; Zheng X; Chen T; Su M; Zhao A; Jia W
Int J Cancer; 2011 Nov; 129(9):2207-17. PubMed ID: 21190195
[TBL] [Abstract][Full Text] [Related]
4. Salivary Tumour Necrosis Factor-α as a Biomarker in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
G D; Nandan SRK; Kulkarni PG
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2087-2093. PubMed ID: 31350970
[TBL] [Abstract][Full Text] [Related]
5. Salivary proteins from dysplastic leukoplakia and oral squamous cell carcinoma and their potential for early detection.
Sivadasan P; Gupta MK; Sathe G; Sudheendra HV; Sunny SP; Renu D; Hari PS; Gowda H; Suresh A; Kuriakose MA; Sirdeshmukh R
J Proteomics; 2020 Feb; 212():103574. PubMed ID: 31706945
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of salivary endothelin-1 levels in oral squamous cell carcinoma and oral leukoplakia.
Hoffmann RR; Yurgel LS; Campos MM
Regul Pept; 2011 Jan; 166(1-3):55-8. PubMed ID: 20727373
[TBL] [Abstract][Full Text] [Related]
7. Salivary KLK5 and uPA are potential biomarkers for malignant transformation of OLK and OLP.
Kang Y; Chen J; Li X; Luo M; Chen H; Cui B; Wang L; Lv D; Feng Y; Zhang P
Cancer Biomark; 2021; 31(4):317-328. PubMed ID: 33896830
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of enzymatic and non-enzymatic antioxidant status and biomarkers of oxidative stress in saliva of patients with oral squamous cell carcinoma and oral leukoplakia: a pilot study.
Babiuch K; Bednarczyk A; Gawlik K; Pawlica-Gosiewska D; Kęsek B; Darczuk D; Stępień P; Chomyszyn-Gajewska M; Kaczmarzyk T
Acta Odontol Scand; 2019 Aug; 77(6):408-418. PubMed ID: 30857448
[No Abstract] [Full Text] [Related]
9. Evaluation of salivary and serum lipid peroxidation, and glutathione in oral leukoplakia and oral squamous cell carcinoma.
Metgud R; Bajaj S
J Oral Sci; 2014 Jun; 56(2):135-42. PubMed ID: 24930750
[TBL] [Abstract][Full Text] [Related]
10. Estimation of salivary lactate dehydrogenase in oral leukoplakia and oral squamous cell carcinoma: a biochemical study.
Patel S; Metgud R
J Cancer Res Ther; 2015; 11(1):119-23. PubMed ID: 25879348
[TBL] [Abstract][Full Text] [Related]
11. Salivary 8-hydroxy-2-deoxyguanosine, malondialdehyde, vitamin C, and vitamin E in oral pre-cancer and cancer: diagnostic value and free radical mechanism of action.
Kaur J; Politis C; Jacobs R
Clin Oral Investig; 2016 Mar; 20(2):315-9. PubMed ID: 26077895
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma.
Sutariya RV; Manjunatha BS
J Exp Ther Oncol; 2016 Nov; 11(4):285-292. PubMed ID: 27849339
[TBL] [Abstract][Full Text] [Related]
13. [Study of salivary metabonomics in patients with oral squamous cell carcinoma and leukoplakia].
Xue JY; Zhu XY; Wei CL; Sun P; Zhang H; Deng J
Shanghai Kou Qiang Yi Xue; 2021 Apr; 30(2):201-205. PubMed ID: 34109363
[TBL] [Abstract][Full Text] [Related]
14. Salivary mRNA markers having the potential to detect oral squamous cell carcinoma segregated from oral leukoplakia with dysplasia.
Michailidou E; Tzimagiorgis G; Chatzopoulou F; Vahtsevanos K; Antoniadis K; Kouidou S; Markopoulos A; Antoniades D
Cancer Epidemiol; 2016 Aug; 43():112-8. PubMed ID: 27263493
[TBL] [Abstract][Full Text] [Related]
15. Metabolomic analysis of the saliva of Japanese patients with oral squamous cell carcinoma.
Ohshima M; Sugahara K; Kasahara K; Katakura A
Oncol Rep; 2017 May; 37(5):2727-2734. PubMed ID: 28393236
[TBL] [Abstract][Full Text] [Related]
16. Identification of salivary metabolic biomarker signatures for oral tongue squamous cell carcinoma.
Vimal J; George NA; Kumar RR; Kattoor J; Kannan S
Arch Oral Biol; 2023 Nov; 155():105780. PubMed ID: 37586141
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-alpha overexpression in proliferative verrucous leukoplakia and oral squamous cell carcinoma: an immunohistochemical study.
Kannan R; Bijur GN; Mallery SR; Beck FM; Sabourin CL; Jewell SD; Schuller DE; Stoner GD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1996 Jul; 82(1):69-74. PubMed ID: 8843456
[TBL] [Abstract][Full Text] [Related]
18. Exploiting salivary miR-31 as a clinical biomarker of oral squamous cell carcinoma.
Liu CJ; Lin SC; Yang CC; Cheng HW; Chang KW
Head Neck; 2012 Feb; 34(2):219-24. PubMed ID: 22083872
[TBL] [Abstract][Full Text] [Related]
19. Salivary lactate dehydrogenase levels in oral leukoplakia and oral squamous cell carcinoma: a biochemical and clinicopathological study.
Shetty SR; Chadha R; Babu S; Kumari S; Bhat S; Achalli S
J Cancer Res Ther; 2012 Jan; 8 Suppl 1():S123-5. PubMed ID: 22322730
[TBL] [Abstract][Full Text] [Related]
20. Salivary metabolomics for oral leukoplakia with and without dysplasia.
Kitabatake K; Ishikawa S; Sugimoto M; Enomoto A; Kaneko M; Ota S; Edamatsu K; Yusa K; Hemmi T; Okuyama N; Iino M
J Stomatol Oral Maxillofac Surg; 2023 Dec; 124(6S):101618. PubMed ID: 37659754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
